STAT6 and STAT1 are essential antagonistic regulators of cell survival in classical Hodgkin lymphoma cell line.
about
The cnidarian origin of the proto-oncogenes NF-κB/STAT and WNT-like oncogenic pathway drives the ctenophores (Review)STAT6 expression in glioblastoma promotes invasive growthSmall interfering RNA against transcription factor STAT6 leads to increased cholesterol synthesis in lung cancer cell lines.Toxoplasma gondii clonal strains all inhibit STAT1 transcriptional activity but polymorphic effectors differentially modulate IFNγ induced gene expression and STAT1 phosphorylationSTAT6 siRNA matrix-loaded gelatin nanocarriers: formulation, characterization, and ex vivo proof of concept using adenocarcinoma cellsThe JAK inhibitor AZD1480 regulates proliferation and immunity in Hodgkin lymphoma.Follicular lymphoma cell niche: identification of a preeminent IL-4-dependent T(FH)-B cell axis.The bone marrow microenvironment enhances multiple myeloma progression by exosome-mediated activation of myeloid-derived suppressor cells.STAT6-mediated BCL6 repression in primary mediastinal B-cell lymphoma (PMBL).Integrated genomic analysis identifies recurrent mutations and evolution patterns driving the initiation and progression of follicular lymphoma.Deregulation of SOCS5 suppresses dendritic cell function in chronic lymphocytic leukemia.Enteric pathogens and gut function: Role of cytokines and STATsCyclovirobuxine D Inhibits Cell Proliferation and Induces Mitochondria-Mediated Apoptosis in Human Gastric Cancer Cells.Novel EPHB4 Receptor Tyrosine Kinase Mutations and Kinomic Pathway Analysis in Lung CancerActivating STAT6 mutations in follicular lymphoma.Follicular lymphomas and their transformation: Past and current research.Dynamically regulated sumoylation of HDAC2 controls p53 deacetylation and restricts apoptosis following genotoxic stress.t(4;8)(q27;q24) in Hodgkin lymphoma cells targets phosphodiesterase PDE5A and homeobox gene ZHX2.Isorhapontigenin (ISO) Inhibits Invasive Bladder Cancer Formation In Vivo and Human Bladder Cancer Invasion In Vitro by Targeting STAT1/FOXO1 Axis.Early thymus and activation-regulated chemokine (TARC) reduction and response following panobinostat treatment in patients with relapsed/refractory Hodgkin lymphoma following autologous stem cell transplant.Association of JAK-STAT pathway related genes with lymphoma risk: results of a European case-control study (EpiLymph).
P2860
Q26799398-BF201812-54CD-4B0B-A8EC-5480167753D0Q30431789-85318030-5B63-4057-814B-8522C94602A2Q34097663-3AEB37DC-8AD2-4021-82E9-4B28599EBC26Q34512387-4C413B86-0675-4E09-8E31-08DF0F875FCDQ35031755-95A5E51F-21BC-406A-8A6B-3B1268A417F1Q35664956-B8696F01-96E9-430D-89FA-BC75900961F9Q35866406-7C5DEA48-93E7-4DEC-B8A3-7A17637B2470Q36685551-CDF63734-3D87-4F9C-A3C6-247C8EC4A48CQ37138531-BD54F0F9-8458-466D-BB38-B8E0BE8B79B6Q37533656-2AEF5410-C4E4-46E3-8FF9-2277B07F9CD0Q37564723-1C169BF4-2647-4E3D-9D63-6CE92A7962C8Q37843657-958321FB-94CD-4963-B8FB-86AE8C0354A8Q38816406-EABA74E7-214A-43B9-AB6A-28C05971FC99Q38864169-4C3C1952-989A-4363-AF47-FC6D75DE146AQ38937478-E7DDBECE-2489-4FB9-AE60-D3C1B91920FAQ39290214-A6B8E780-A23A-4FDD-9DA6-FD9EA6F8AA4FQ39366270-96A6DC98-159B-4282-9AF3-D341446AB960Q39460302-CA191C97-07A8-4B32-B682-7FA3CAAD1F05Q39849534-DBE9B07D-F4D1-46E8-9A38-312FA7421AA3Q50861558-0AA41783-5E9C-4432-8C34-1091A180B3D9Q53260519-22AD3B4D-6C3C-42E6-B32E-E712CAC27D20
P2860
STAT6 and STAT1 are essential antagonistic regulators of cell survival in classical Hodgkin lymphoma cell line.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
STAT6 and STAT1 are essential ...... al Hodgkin lymphoma cell line.
@en
type
label
STAT6 and STAT1 are essential ...... al Hodgkin lymphoma cell line.
@en
prefLabel
STAT6 and STAT1 are essential ...... al Hodgkin lymphoma cell line.
@en
P2093
P2860
P356
P1433
P1476
STAT6 and STAT1 are essential ...... al Hodgkin lymphoma cell line.
@en
P2093
C Bräutigam
E Pfitzner
F Nonnenmacher
M-L Hansmann
S Jankowski
P2860
P2888
P304
P356
10.1038/LEU.2009.103
P577
2009-05-14T00:00:00Z
P5875
P6179
1011869171